Table: Stella Pharma - 9-MTH parent results

Stella Pharma

12/02/2025 05:00

Feb 12 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Dec 31, 2024        Dec 31, 2023      Mar 31, 2025 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            254 mln             200 mln          930 mln    
                 (+26.9 pct)         (+14.3 pct)      (+245.1 pct) 
  Operating     loss 375 mln        loss 466 mln      loss 252 mln 
  Recurring     loss 371 mln        loss 466 mln      loss 257 mln 
  Net           loss 373 mln        loss 469 mln      loss 260 mln 
  EPS          loss 11.27 yen      loss 15.19 yen    loss 8.33 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T